Detalhe da pesquisa
1.
Deubiquitinase USP9X loss sensitizes renal cancer cells to mTOR inhibition.
Int J Cancer
; 153(6): 1300-1312, 2023 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37260183
2.
PTEN expression and mutations in TSC1, TSC2 and MTOR are associated with response to rapalogs in patients with renal cell carcinoma.
Int J Cancer
; 146(5): 1435-1444, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31335987
3.
Hsa-miR-139-5p is a prognostic thyroid cancer marker involved in HNRNPF-mediated alternative splicing.
Int J Cancer
; 146(2): 521-530, 2020 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31403184
4.
Concomitant Medications and Risk of Chemotherapy-Induced Peripheral Neuropathy.
Oncologist
; 24(8): e784-e792, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30470691
5.
Gain-of-function mutations in DNMT3A in patients with paraganglioma.
Genet Med
; 20(12): 1644-1651, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29740169
6.
PBRM1 and KDM5C cooperate to define high-angiogenesis tumors and increased antiangiogenic response in renal cancer.
Am J Cancer Res
; 13(5): 2116-2125, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37293154
7.
Physical interactions between MCM and Rad51 facilitate replication fork lesion bypass and ssDNA gap filling by non-recombinogenic functions.
Cell Rep
; 36(4): 109440, 2021 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34320356
8.
Novel DNMT3A Germline Variant in a Patient with Multiple Paragangliomas and Papillary Thyroid Carcinoma.
Cancers (Basel)
; 12(11)2020 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33182397
9.
PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics.
J Mol Diagn
; 19(4): 575-588, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28552549
10.
mTOR Pathway Mutations and Response to Rapalogs in RCC-Letter.
Clin Cancer Res
; 23(17): 5320, 2017 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28864728